CEO of British Patient Capital appointed to Government taskforce
Press release
Judith Hartley, CEO of British Patient Capital and British Business Investments, has been appointed to a new Women-Led High Growth Taskforce set up by the Cabinet Office.
Chaired by Anne Boden, CEO of Starling Bank, the aim of the Taskforce is to influence high-growth investors and the wider business community, and raise the aspirations of the next generation of women entrepreneurs.
The formation of a Taskforce with a laser focus on increasing the number of women-led, high growth businesses is incredibly important. Diversity within investment teams and in the companies they back ensures diversity of ideas – and that is a cornerstone of innovation. At British Patient Capital, we work hard to ensure we have good diversity at all levels within our team. As the UK’s largest investor in venture and growth capital, we firmly believe we have a role to play in demonstrating best practice and driving change across the industry. I look forward to supporting the Taskforce to improve awareness and understanding of the key barriers faced by female entrepreneurs in accessing high growth capital, and championing the vital role of women-led business in the UK economy. Judith Hartley CEO, British Patient Capital
Further Information
Notes to editors
About British Patient Capital
British Patient Capital is the trading name of British Patient Capital Limited, a wholly-owned commercial subsidiary of British Business Bank plc, the UK government’s economic development bank. It forms part of the British Business Bank plc’s commercial arm.
Its mission is to enable long-term investment in innovative firms led by ambitious entrepreneurs who want to build large scale businesses. Launched in June 2018, British Patient Capital has £2.5bn to invest over 10 years in venture and venture growth capital to support high growth potential innovative UK businesses in accessing the long-term financing they require to scale up. Find out more at britishpatientcapital.co.uk.
British Business Bank plc and its subsidiary entities are not banking institutions and do not operate as such. They are not authorised or regulated by the Prudential Regulation Authority (PRA) or the Financial Conduct Authority (FCA). A complete legal structure chart for British Business Bank plc and its subsidiaries can be found on the British Business Bank plc website.
British Patient Capital makes commitments and invests on its own behalf and on behalf of third-party investors whose investments British Patient Capital manages.
Latest news
-
Read more about British Patient Capital – Full Year Results for the period ending 31 March 2024 Press release
04 November 2024 -
Read more about British Patient Capital announces £8m investment into Nuclera as part of a $75m Series C financing round Press release
16 October 2024 -
Read more about British Patient Capital announces investment into Purespring Therapeutics as part of £80m Series B financing round Press release
09 October 2024